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Abstract Certain styrenic thermoplastic block copolymer
elastomers can be processed to exhibit anisotropic
mechanical properties which may be desirable for imitating
biological tissues. The ex-vivo hemocompatibility of four
triblock (hard–soft–hard) copolymers with polystyrene
hard blocks and polyethylene, polypropylene, polyiso-
prene, polybutadiene or polyisobutylene soft blocks are
tested using the modified Chandler loop method using fresh
human blood and direct contact cell proliferation of
fibroblasts upon the materials. The hemocompatibility and
durability performance of a heparin coating is also evalu-
ated. Measures of platelet and coagulation cascade acti-
vation indicate that the test materials are superior to
polyester but inferior to expanded polytetrafluoroethylene
and bovine pericardium reference materials. Against
inflammatory measures the test materials are superior to
polyester and bovine pericardium. The addition of a hep-
arin coating results in reduced protein adsorption and ex-
vivo hemocompatibility performance superior to all refer-
ence materials, in all measures. The tested styrenic ther-
moplastic block copolymers demonstrate adequate
performance for blood contacting applications.
1 Introduction
Polymeric elastomers have widespread uses as biomateri-
als, but the full scope of their potential use has not been
realised. Elastomeric materials are attractive as their
properties are tuneable, and their mechanical properties are
similar to native biological materials. A subset of poly-
meric elastomers possess another property, giving them a
desirable analogy with biological materials: anisotropic
mechanical properties, that can be induced during pro-
cessing for some types of block copolymers [1]. In par-
ticular, styrenic block copolymers can exhibit a cylindrical
morphology when the fraction of styrene is approximately
18–30 % and the other block is a polyolefin such as
polyethylene, polyisoprene, or polyisobutylene [2]. Styre-
nic block copolymers are relatively easy to process via
extrusion or injection moulding, and the process of shear-
ing or stretching during moulding can be used to align the
cylinders, and this alignment is preserved upon cooling [3,
4]. The alignment of the glassy polystyrene cylinders
results in macroscopic anisotropic properties. Such triblock
copolymers also exhibit a form of physical cross-linking
between the polystyrene domains, which improves their
durability.
The opportunity to fabricate heart valve prostheses
from thermoplastic elastomers shows great potential [3,
39]. Bioprosthetic valves are a current gold standard
prosthesis used to treat heart valve disease. Unfortunately,
their durability is a significant shortcoming [5]. Alterna-
tively, mechanical valves have lifelong durability, but are
accompanied by the requirement for anticoagulation
therapy. Polymeric valves have been hailed as offering a
potential solution, which may be able to overcome issues
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The anisotropic mechanical properties of native heart
valves are well characterised and are recognised as
essential requirements for the observed durability of
native heart valves [7]. Given this premise, the use of
cylinder forming block copolymers, which have aniso-
tropic mechanical properties, is a promising application.
In this study, we investigate the hemocompatibility of a
selection of styrenic block copolymers. We selected one
of these polymers for a prosthetic heart valve application,
which was coated with a commercial heparin coating. The
selected material also underwent direct contact cell via-
bility testing.
Poly(styrene-block-isobutylene-block-styrene) (SIBS) is
already in use as a biomaterial for blood-contacting
applications as part of the TAXUS stent. It has also been
tested as a polymeric prosthetic heart valve material [8].
Other cylinder-forming block copolymers have been used
to fabricate valves for which the hydrodynamics are good
[9]. In this study, we publish ex vivo hemocompatibility
data for a range of saturated and unsaturated, cylinder-
forming block copolymer materials which may be used in a
prosthetic heart valve.
2 Materials and methods
2.1 Block copolymer samples
Styrenic block copolymers are produced by anionic poly-
merisation. Four cylinder-forming block copolymers were
examined: polystyrene-block-polyisoprene-block-polystyrene,
containing 30 wt% styrene (commercial product name Kraton
D1164P); polystyrene-block-polyisoprene-block-polybutadi-
ene-block-polystyrene (commercial product name Kraton
D1171 PT), with a polystyrene content of 19 % denoted as SI/
BS19; polystyrene-block-polyethylene-polypropylene-block-
polystyrene (commercial product name Kraton G1730) with a
polystyrene content of 22 %; and polystyrene-block-poly-
isobutylene-block-polystyrene having 30 % wt styrene, man-
ufactured by Innovia LLC., denoted in this paper as SIS30, SI-
BS19, SEPS22 and SIBS30 respectively. All are linear block
copolymers.
Expanded polytetrafluoroethylene (ePTFE) and polye-
ster vascular grafts, manufactured by Jostent, were used as
reference materials.
We also compared our selected polymer to a commer-
cially available glutaraldehyde-fixed Bovine Pericardium
patch (trade name Peri-Guard, with Apex Processing,
Synovis Life Technologies, Inc. MN, USA). In ‘Apex
Processing’ the patch is chemically sterilized using ethanol
and propylene oxide, and treated with 1 molar sodium
hydroxide for 60–75 min at 20–25 C. This results in
\5 ppm residual glutaraldehyde, and is a method used to
reduce calcification and improve the hemocompatibility of
bioprosthetic heart valves.
2.2 Sample preparation
All block copolymer samples were compression moulded
at 150 C in an electrically heated hydraulic press to a
thickness of 0.3 mm. Strips of 9 9 150 mm2 were then cut
from the polymer sheet for tests in the modified Chandler
loop. Samples were sterilized with ethanol before testing.
The polymer was primed for coating by forming a
cationic surface on the uncharged synthetic material. This
was then heparin coated by exposing to a dilute water
solution containing heparin conjugate manufactured by
Corline (Uppsala, Sweden). The heparin conjugate binds
to any cationic surface with very strong affinity due to the
multiplicity of anionic groups [10, 11].
2.3 Coating
To increase blood compatibility of materials, which display
superior mechanical properties the use of chemical modi-
fications like heparin coating have been studied in great
detail. In the Corline heparin coating, approximately 70
heparin molecules are bound to a polyamine chain, which
is in turn bound to the substrate [12].
2.4 Chandler-loop model
According to ISO 10993-1 potential biomaterials for car-
diovascular applications should undergo testing for their
hemo- and cyto-compatibility. Experiments were per-
formed using an ex vivo closed loop model (modified
Chandler-loop) which uses a minimum of fresh human
donor blood, induces physiological shear rates and has a
high degree of sensitivity to material type [13–15]. The
modified Chandler-loop system consists of a thermostated
water bath (37 C) and a rotating unit with attached poly-
vinyl chloride (PVC) loops. A strip of material is placed
tightly inside a tube, the tube is filled with fresh human
blood and closed to form a loop (Fig. 1) [16]. The PVC
loops were coated with covalently bonded heparin (CBAS,
Carmeda bioactive surface, Medtronic Anaheim, CA,
USA) to minimize background activation. All tests were
performed on samples of identical geometry so hemody-
namic effects are eliminated.
Each loop (length: 50 cm, ID: 0.95 cm) was filled with
20 ml blood from one donor and then firmly closed into
circuits with a short piece of silicone tubing outside of the
loop tubing. The loops were rotated vertically at 30 rpm in
the water bath (37 C). At 30 rpm a half-filled Chandler
loop generates shear rates in the blood of between 50 and
300 s-1 [30], which are comparable to those found in
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major arteries [31]. After 90 min of circulation the blood
was collected in appropriate syringes [15].
2.5 Reference materials
The hemocompatibility of the styrenic block copolymers
was compared to 2 commonly used cardiovascular bioma-
terials: ePTFE and polyester. ePTFE is an excellent bio-
material, resulting in very little activation of the coagulation
cascade [17], and is commonly used in left ventricular
outflow tract reconstruction. Polyester is a thrombogenic
material which is commonly used in the sewing rings of
prosthetic heart valves. A single block copolymer was
selected (on the basis of its desirable properties for pros-
thetic heart valve applications), and a heparin coating was
applied to this STE. This was compared to ePTFE and
glutaraldehyde-fixed bovine pericardium.
2.6 Blood drawing
Blood was collected from non-medicated, healthy volunteers
(n = 6) by venipuncture with a 1.4 mm butterfly cannula
from a large antecubital vein into sterile and pre-anticoagu-
lated containers. The blood was anticoagulated with 1.5 IU/
Heparin-Natrium 25000 (Rathiopharm GmbH, Ulm, Ger-
many). Blood sampling procedures were approved by the
ethics committee of the University of Tuebingen, Gemany.
Blood from each donor was split between one donor
control sample, one tubing control sample, the test item
samples, and the reference samples.
2.7 Hemocompatibility tests
Blood compatibility tests were performed using an ex vivo
system according to ISO 10993-4 [15], including measures
of thrombogenicity, activation of coagulation, blood cell
counts, platelet activation, and inflammatory response
containing complement activation and secretion of poly-
morphonuclear elastase (PMN-elastase) from neutrophils.
2.8 Blood sampling
Samples were taken before addition to the Chandler-loop,
and after 90 min of circulation in the Chandler-loop. 20 ml
samples were divided as follows:
2.7 ml EDTA-blood for complement and blood cells
analysis (potassium-EDTA, 1.6 mg/ml).
10 ml citrated blood for PMN-elastase, thrombin-an-
tithrombin complex (TAT) and hemolysis analysis
(0.14 ml citrate solution, 0.106 M C6H5Na3O72H2O).
4.5 ml blood in CTAD-vacutainer medium for b-throm-
boglobulin analysis (450 ll of 0.109 M, CTAD Becton–
Dickinson GmbH, Heidelberg, Germany).
2.9 Analyses of activation markers
The samples were centrifuged immediately at 1800 or
20009g for 20 min with a cryofuge (Model 8000, Heraeus,
Osterode, Germany). Plasma of the blood samples were
then aliquoted in 200 ll samples and shock frozen in liquid
nitrogen with subsequent storage at -80 C for further
investigations. Changes in markers of coagulation and
complement activation as well as blood cell release factors
were measured by commercially available ELISA kits.
Samples were analysed for b-thromboglobulin (Asser-
achrom b-TG, Diagnostica Stago, Asnieres, France), and
thrombin-antithrombin-III complex (Enzygnost TAT micro,
Siemens Healthcare, Marburg, Germany) to evaluate platelet
activation and activation of the coagulation system. Adsorbed
Fig. 1 Schematic of Chandler-
loop
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fibrinogen and adsorbed CD41 to the samples were measured
using a modified ELISA method as described in [18].
Leukocyte and complement activation were detected by
measurements of PMN-elastase (PMN-Elastase ELISA,
Demeditec Diagnostics GmbH, Kiel, Germany) and SC5b-
9 (Osteomedical GmbH, Bu¨nde, Germany).
2.10 Blood cell count
Cell counts were measured in EDTA-blood (potassium-
EDTA, 1.6 mg/ml) immediately after sampling using a
fully automated cell counter system (micros 60 ABX
Hematology, Montpellier, France). Hemolysis was detec-
ted using a colorimetric assay for free plasma hemoglobin
(Cyan haemoglobin test, UKT, Germany).
2.11 Morphology
After circulation in the loop, the samples were pho-
tographed and visually inspected for thrombi. The polymer
samples were incubated overnight in 2 % glutaraldehyde
(Serva, Heidelberg, Germany) containing PBS (phosphate
buffered saline, Invitrogen Gibco, Karlsruhe, Germany)
solution and subsequently rinsed in pure PBS. The
remaining water was then removed from the samples using
40–100 % of ethanol (Merck, Darmstadt, Germany) in
ascending concentrations. Finally, all samples were critical
point dried sputtered with gold palladium and afterwards
analysed with scanning electron microscopy (SEM)
(Cambridge Instruments, Cambridge UK, type 250 MK2).
2.12 Cell viability
The direct contact viability of cells upon the material is
necessary for the biocompatibility of a long term implant.
We evaluated the viability of murine fibroblasts (L929)
upon the materials according to ASTM standards [19].
70 % ethanol was used as a negative control, SEPS22 and
Heparin Coated SEPS22 were compared to the ePTFE and
polyester graft materials, Pellethane 2363-80AE (Velox,
UK), and polystyrene wells without material. Pellethane
2363 80AE underwent significant testing as a polyurethane
elastomer with potential heart valve application in the
1990s, so we used this as a reference material [20, 21].
The established cell line L929 (LGC Standards, UK)
was cultured directly upon the materials (n = 6), which
were placed in 96 well plates for 48 h. Cell count was
assessed using an MTS assay (CellTiter96, Promega, UK).
2.13 Coating durability
The heparin conjugate covalently bonds to the polymer
through a disulphide coupling unit, which is a useful
marker for the XPS evaluation. Coated specimens were
exposed to various environments, in vitro, for 500 h to
evaluate their effect on heparin coating durability [12].
Four environments, all at 37 C, were investigated: (1) air;
(2) PBS solution; demonstrating the effect of simulated
physiological conditions; (3) dynamic stretching of the
material in PBS solution, at 3 Hz frequency, reaching a
maximum tensile strain of 15 % using a 3-point bend
geometry, with a fully relaxed minimum strain, which
represented conditions of a heart valve operation, though
was not intended as means of assessing the mechanical
durability of the bulk material; (4) H2O2 [3 % (v/v)]
solution demonstrating the effect of oxidising agents pre-
sent in blood. The chemical constitution of the heparin
coated test specimens and uncoated-control material were
explored with X-ray photoelectron spectroscopy (XPS) and
water contact angle measurements. XPS samples were
analysed using Kratos Axis Nova XPS system with an Al
Ka (1486.6 eV) source.
Three samples from each environment were analysed by
contact angle measurement (seven spots) and XPS (five
spots).
The concentration of heparin which leached from the
coating into the PBS solution was determined using the
toluidine blue method [22–26]. Polymer samples (65 cm2)
were stored in glass vials containing 20 ml of phosphate
buffered saline (PBS), pH 7.4 at room temperature. Peri-
odically, the supernatant, (2 ml) of the PBS solution was
taken and mixed with a 0.005 % toluidine blue solution
(2 ml). Following heparin-dye-precipitation, the absorbance
of the dye-depleted solution at 631 nm was measured and
the concentration of the released heparin was calculated
from the heparin calibration curve constructed using sodium
heparin salt from intestinal mucosal source (Sigma, UK).
2.14 Statistics
Results were analysed using Matlab (r2014a). A two tail
ANOVA with the Bonferroni correction was used to
compare normally distributed samples of equal size.
3 Results
3.1 Hemolysis and coagulation
In the full blood count, there were no significant differ-
ences between materials for red blood cell counts. Free
hemoglobin concentration is a marker of red blood cell
destruction, which would result in a material being highly
incompatible with human blood. SI-BS19 and SIBS30
resulted in less hemolysis than the reference materials
(Fig. 2a).
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We did not observe any significant thrombus generation
on the surface of the polymeric materials (Table 1).
However, there was some surface thrombus generation on
the bovine pericardium materials.
Materials without surface thrombi may still cause clot-
ting through activation of the coagulation cascade. The
generation of thrombin occurs in the common pathway of
the coagulation cascade. We measure the concentration of
TAT in blood before and after contact with the materials.
All uncoated STE resulted in more TAT generation than
ePTFE and bovine pericardium, but not more than polye-
ster. The addition of Heparin coating resulted in the least
activation. Bovine pericardium also had a superior per-
formance than ePTFE, on this measure.
The generation of thrombin-antithrombin complex
occurs in the common pathway of the coagulation cascade.
As such, this is a sensitive marker of activation. Bovine
pericardium resulted in a lower TAT generation than
ePTFE. In this case, all uncoated test materials resulted in
significantly more TAT generation than PTFE. However,
the addition of heparin coating to SEPS22 resulted in the
lowest TAT generation.
3.2 Platelets
When platelets come into contact with a foreign surface
they can be activated. Activation proceeds through the
formation of pseudopodia, adhesion, aggregation and
release of platelet factors from the granules. All uncoated
materials caused a drop in platelet count either through
activation or adsorption of the platelets to the material.
STEs, ePTFE and bovine pericardium showed similar
changes in platelet counts, whereas polyester resulted in a
significant reduction in platelets. If platelets are activated,
then b-thromboglobulin (b-TG) is released; STEs, polye-
ster and bovine pericardium resulted in a similar level of b-
TG release (Fig. 3b). ePTFE and the addition of a Heparin
coating to SEPS22 led to lower b-TG levels.
3.3 Innate immune response
Foreign materials can active the innate immune system.
Before and after circulation in the Chandler loop we
measure white blood cell (WBC) count, release of PMN-
elastase, and the concentration of SC5b-9.
The STE materials did not have a significant effect on
WBC count. There was however a significant reduction
(P\ 0.05) in WBC count for samples contacted with
polyester and bovine pericardium (Fig. 4a).
PMN-elastase is secreted by neutrophils during inflam-
mation; bovine pericardium and polyester resulted in
greater releases of PMN-elastase than the tested STE
(Fig. 4b). The coating of SEPS22 with heparin had no
effect on either of these inflammatory measures.
Plasma protein SC5-b9 is used to lyse pathogenic cells
in the final stage of the complement cascade, where the
alternative and classical pathways converge [27], and is a
marker of the degree of inflammatory response, which may
be promoted by a material. All materials led to some
activation of the complement cascade, though none as
much as bovine pericardium which resulted in significantly
































































































































































































Run 1 Run 2
(a) (b)
Fig. 2 Free hemoglobin is released during hemolysis and was
measured using a photometrical test. None of the materials caused
significant hemolysis (a). Thrombin is generated in the common
pathway of the coagulation cascade. We measured the concentration
of thrombin-antithrombin complex. All materials activated the
coagulation cascade (b)
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3.4 Scanning electron microscopy
Under SEM, we observed morphological differences in the
proteins adsorbed on the surface of each polymer. A sub-
confluent protein layer was adsorbed onto the uncoated
polymeric materials (Table 1). The protein layer was
fibrous with some cellular entrapment and branching of
fibres. In contrast, the heparin coated samples resulted in
qualitatively sparser protein adsorption, in which protein
fibres did not become conjoined (Table 1).
Table 1 SEM images of polymer surfaces before and after contact with blood
Sample name, (scale bar length) No blood contact After 90 min blood contact
SEPS22, uncoated (10 lm)
SEPS22, Heparin coating (10 lm)
Photograph of bovine pericardium sample
after blood contact (scale marked in cm)
Bovine pericardium after blood contact
(both images). (1 mm, 100 lm)
The coated and uncoated surfaces are macro and microscopically smooth, but have a protein coating after blood contact. The uncoated sample
appears to have activated platelets adsorbed to its surface, the uncoated surface has a confluent layer of fibrin, but no activated platelets on the
surface. The bovine pericardium sample after blood contact shows adherence of blood to the surface of the material. Under SEM, a mild
thrombus can be seen upon the surface
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3.5 Cell viability
We measured the viability of L929 murine fibroblast cells
in direct contact with SEPS22, heparin coated SEPS22, and
the reference materials. The test materials resulted in the
highest growth rate of fibroblast cells upon the surface
(Fig. 4d); no differences were observed between coated
and uncoated SEPS22 samples.
The rapid proliferation of murine fibroblasts on the
surface of the materials implies that cells are viable on the
material. There was no significant difference between












































































































































































































































































































































































































Fig. 3 The STE and reference materials led to the loss of platelets.
Platelets may be adsorbed to the material surface, aggregate to each
other, or become activated, releasing a-granules. The reduction in
platelet count (a) indicates that platelets may be adsorbed or
activated. Activation of platelets leads to the release of b-throm-
boglobulin (b-TG) (b), analysed by ELISA. b-TG was significantly
greater for the STE than for the hemocompatible reference, ePTFE.
Adsorption of platelets to the material surface can result in the
deposition of CD41 receptor protein on the material surface (c). The
STE materials had significantly less adsorbed CD41 than the negative
reference, polyester. Heparin coating of SEPS22 also reduced CD41
adsorption. Platelets and leukocytes can bind to fibrinogen which is
adsorbed to the material’s surface. High levels of adsorbed fibrinogen
lead to thrombus generation and localised inflammation [28].
Fibrinogen adsorption was significantly lower on the STE than on
the reference materials (d)
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heparin coated surfaces of SEPS22, suggesting that method
of manufacture is unlikely to be an issue, and heparin did
not influence the fibroblasts. All methods of manufacture
resulted in relatively smooth surfaces. By contrast, the
reference materials were not macroscopically flat and















































































































































































































































































































































































Fig. 4 Activation of leukocytes occurs during inflammation and results
in the release of PMN elastase and loss of WBC. Polyester and bovine
pericardium both led to a significant reduction in leukocyte counts. None
of the STEs led to a fall in leukocyte numbers (a). The concentration of
PMN elastase was analysed by ELISA, all materials led to release,
though all of the STEs were significantly less inflammatory than both
polyester and bovine pericardium (b). SC5b-9 is associated with the final
stage of the complement cascade and leads to the formation of membrane
attack complexes that are used to perforate the membrane of a pathogen
or cell. All materials led to the activation of the complement cascade,
though all polymers were significantly less inflammatory than bovine
pericardium (c). d Cells are viable on SEPS22 STE materials, with no
significant differences between manufacturing methods nor coating.
Direct contact cell culture of murine fibroblasts L929, cell count after
48 h using MTS assay. EtOH is 70 % ethanol, S22 Sol is SEPS22 solvent
cast (10 w/v%) with toluene
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influence the extent to which cells could propagate. Cells
were not viable on the bovine pericardium surfaces, which
was likely to be due to some residual leaching of glu-
taraldehyde, which was used in fixation.
3.6 Heparin coating durability
Heparin coated samples were aged statically in air,
hydrogen peroxide and PBS, and also dynamically in PBS
for 500 h. Using XPS we detected the presence of the
OSO3 and NSO3 groups, which are found in active heparin
(Fig. 5a). Heparin coated samples have a lower water
contact angle than uncoated samples (Fig. 5d).
Each degradation method lead to a reduction in Heparin
functional group concentration (Fig. 5b) and change in
surface hydrophobicity (Fig. 5d). The samples which were
strained dynamically have a significantly greater contact
angle than those which are held statically (P = 0.0029) and
lower sulphate group concentration, which suggests that
coating has been altered or removed.
The heparin-coated materials which were dynamically
strained, were not significantly different to the static sam-
ples, though there was a reduction in sulphate surface
concentration for both sets of samples. There was a severe
reduction in surface concentration for the samples, which
were statically stored in oxidising solution. The least
amount of heparin was present on samples exposed to
oxidising solution. The average area of the S 2p spectra for
specimens immersed in PBS solution in both static and
dynamic conditions was very similar (Fig. 5b), which
indicates that the dynamic stretching did not induce addi-
tional release of heparin from the surface. Furthermore, for
samples stored in PBS solution phosphate spectra were also
detected, suggesting that the heparin coating may have
become partially covered by a layer of phosphate salts.
This in turn could have contributed to a slight decrease of
the sulphur peak from heparin.
Figure 5c shows that the percentage of released heparin
increased sharply during the first day of the immersion
before the release curve plateau at around 8 % of the
Fig. 5 a Representative XPS spectra for sulphur from heparin coated
polymers exposed to various environments for 500 h and for uncoated
material (control). b Average S 2p peak area calculated from 15
measurements for each tested environment. PBS Dyn corresponds to
samples stored in PBS and dynamically strained. H202 corresponds to
samples stored in an oxidising environment. c Heparin concentration
in PBS from heparin samples incubated in PBS solution. d Contact
angle of water droplets on heparin coated samples in different
environments
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adsorbed heparin. The observed heparin release was
probably due to physically adsorbed heparin on the poly-
mer surface, which diffused to the PBS solution during the
first day of the experiment. As the heparin coated samples
were thoroughly washed during sterilisation, and the
adsorbed protein profiles are significantly different, it is
unlikely that the biocompatibility improvements are a
result of heparin leaching.
4 Discussion
In this study we have used the Chandler loop model to
characterise the ex vivo response of human blood to
implantable materials.
The Chandler loop model is able to produce thrombi
which are very similar to those observed in vivo [29].
Furthermore, the average shear rates generated by the
Chandler loop with dimensions and rotation rate as previ-
ously described are comparable to those found in a major
artery of 50–300 s-1 [30, 31]. For the majority of hemo-
compatibility measures, the modified Chandler loop was
successful at removing background activation: there were
only small differences between the fresh blood and control
tube results for inflammatory measures and platelet acti-
vation. The ex vivo Chandler loop requires blood to be
mildly heparinised prior to testing, increasing the activity
of antithrombin, and so reducing coagulation. We used the
concentration of thrombin as a marker for activation of the
coagulation cascade, which would have been influenced by
the use of heparin. Although absolute concentrations are
inconsequential, the relative values are unaffected.
Day-to-day and donor-to-donor variation is a significant
consideration in biocompatibility testing [32]. As such,
absolute analyte levels for the test materials should be
compared to the reference material results. PTFE, polye-
ster, and bovine pericardium are used extensively in in vivo
and ex vivo vascular implants and are appropriate choices
of reference materials as the host response is well charac-
terised. ePTFE is an inert biomaterial with good hemo-
compatibility. ePTFE is characterised by its highly
hydrophobic surface and lack of functional groups, its
major performance draw back as a graft material is its
restenosis in small vessels. As a prosthetic heart valve
material it suffers from excessive calcification and poor
durability [6]. The use of polyester (Dacron) in heart valve
applications is limited to the sewing ring where it is rapidly
encapsulated in fibrous tissue. When used as leaflets in
polymeric prosthetic heart valves the material has in vivo
failure [33].
Although bovine pericardium is widely used as a graft
and heart valve material with good results, there are few
reports of the ex vivo hemocompatibility of bovine
pericardium in the literature. In our study, the pericardium
had minimal thrombogenicity and activation of the coag-
ulation cascade, which are reflective of its in vivo perfor-
mance; pericardial leaflets on prosthetic heart valves do not
require major anticoagulation therapies, aspirin suffices.
Among all materials, the inflammatory measurements
(WBC count, PMN elastase, SC5b-9) were greatest for
blood contacted with pericardium, as might be expected
from a xenographic transplant. Improved pericardium
processing methods, with alternatives to glutaraldehyde,
could improve cell viability and reduce inflammation [34].
The pericardium used in this study did not undergo any
anticalcification treatments, such as ethanol incubation,
detoxification, or coating, which may be used on biopros-
thetic heart valves, however the pericardium is a material
in clinical use with acceptable hemocompatibility.
The STE materials did not cause significant hemolysis
or activation of the coagulation cascade relative to ePTFE.
Activation of platelets can be inferred from a release of b-
TG, while the adsorption of CD41 to a surface is an artefact
of platelet adsorption to the surface. Platelet activation was
lowest for ePTFE, but was closely followed by the test
STE. High levels of adsorbed CD41 may not correlate with
SEM images of adsorbed platelets because they may have
become washed off due to flow during the test [35].
Polyester resulted in significantly greater destruction of
platelets and adsorption of CD41. The test STEs were
significantly less activating and adsorbing than polyester.
Contact with ePTFE resulted in significantly less b-TG
release than contact with STEs. However, adsorbed CD41
levels were not significantly different between STEs and
ePTFE, possibly due to the hydrophobic surface of both
materials. The addition of the heparin coating mediated the
activation and adsorption response, resulting in the mini-
mum platelet activation.
There were only minor differences in hemocompatibility
between the 4 types of STE. The soft block (polyethylene,
polyisoprene, or polyisobutylene) is expected to coat the
surface of the block copolymer materials and the minor
differences in molecular architecture do not affect the
surface properties (surface energy) significantly. The
absence of hydroxyl and amine groups in the shortlisted
biomaterials is a useful property in minimising the acti-
vation of the (alternative) complement cascade [36]. The
protein adsorption profiles for the STEs are relatively
similar to ePTFE and bovine pericardium so we might
expect the long term biocompatibility performance of the
polymers to be similar.
The adsorption of proteins is indicative of the long term
performance of a biomaterial, in particular, elevated fib-
rinogen adsorption aids the adhesion of platelets and
macrophages which can lead to a chronic, local, inflam-
matory reaction. SEPS22 and SI-BS19 resulted in
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significantly lower protein adsorption than occurred on
ePTFE. Heparin coated samples resulted in a minimum of
CD41 and fibrinogen adsorption suggesting that as long as
the coating is present and active, superior biocompatibility
may be achieved.
The polymeric materials were not cytotoxic. In the heart
valve scenario, the proliferation of fibroblasts should
ensure good colonisation around the sewing ring, and
possibly aid the fibrous encapsulation of the leaflets which
may reduce the rate of calcification. In situ endotheliali-
sation from anastomoses over distances greater than
10 mm is unlikely. Further work would evaluate the
response of monocyte-macrophage cultures to surface
contact.
The addition of a heparin coating is well known to
improve hemocompatibility by reducing the hydrophobic-
ity of polymer materials [37], as well as having a biological
interaction with plasma proteins [38]. The reduction in
protein adsorption, as measured by assay and observed
under SEM, helps to reduce coagulation and inflammatory
activation, resulting in the most hemocompatible material
in these tests.
These experiments are limited to 90 min of ex vivo
circulation, and so the long term performance of the hep-
arin coating was evaluated separately. The in vitro ageing
indicated that some heparin may be lost during the washing
phase, followed by a slow release of heparin over a period
of weeks and months. Dynamically stretching the polymer
or ageing in hydrogen peroxide destroyed the coating. The
durability of the Corline heparin surface on pyrolytic car-
bon was evaluated by [12] using XPS and antithrombin
binding capacity. Although they also observed a loss in
heparin conjugates from the carrier chain after 3 weeks of
continuous high shear flow, there was no reduction in
antithrombin binding capacity.
The inactivation of heparin via ion-exchange mecha-
nisms with endogenous cations and proteins has also been
reported suggesting that long term performance is unlikely
to be satisfactory even if heparin is not leached from the
surface [38]. Heparin may mediate the short and medium
term response and ideally lead to formation of a stable fi-
brous capsule, but long term performance requires further
investigation, particularly for this polymeric substrate.
Patients receiving a cardiovascular implant often require
a therapeutic drug regime either as a consequence of their
pathology, or the implant. Patients receive at least
3 months of aspirin or another anticoagulant therapy in
conjunction with a bioprosthetic heart valve implant. We
considered the effect of these drugs upon the blood
response through the in vitro addition of salicylic acid. In
general, this resulted in a damping of the response to the
tested biomaterial. However, we did observe that the
combination of ex vivo aspirin and heparin coating of
materials did not provide any benefit over either one used
separately.
5 Conclusions
A shortlist of nano-cylinder forming block copolymers
were tested for hemocompatibility according to ISO
10993:4 with a view towards their application in cardio-
vascular devices, particularly polymer based prosthetic
heart valves. None of the STE test materials elicited an
adverse host response in hemocompatibility or direct
fibroblast contact results. Ex vivo tests resulted in minimal
hemolysis and immune system activation. The uncoated
STEs which were tested performed better than polyester in
terms of platelet activation and inflammation. SIBS has
received considerable attention as a ‘biocompatible’
material, in this study we show that this accolade may be
extended to several other STEs [39]. Furthermore, the
addition of a heparin coating results in a significant
improvement in hemocompatibility parameters. Although
some leaching occurs in the first hours of contact, the
coating is stable for at least 10 days in static solutions. The
heparin coating was found to be largely still present after
500 h of testing under dynamic stretching in PBS, though
was degraded after contact with oxidants.
In conclusion it is possible to rank the polymeric mate-
rials in terms of increasing activation of the coagulation
cascade: heparin coated SEPS22\bovine pericardium\
ePTFE\SEPS22 = SI/BS19 = SIBS30 = SIS30\polye-
ster. And also in terms of increasing inflammatory reaction:
heparin coated SEPS22\SEPS22 = SI/BS19 = SIBS30 =
SIS30 = ePTFE\ bovine pericardium = polyester.
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